Driving down cost and time for cell therapy manufacturing: an interview with Ali Mohamed, Immatics

Written by RegMedNet

In this interview with Ali Mohamed, Immatics (TX, USA) discusses how automation, digitization and integrated processes could be used to reduce time and cost of manufacturing cell therapies.

 

Cell therapies could be transformative; however, the manufacturing time and cost-of-goods remains high. In this interview, Ali Mohamed, Vice President for Chemistry, Manufacturing, and Control (CMC), Immatics (TX, USA), discusses how the industry could work to lower the time and cost of manufacturing cell therapies in the future.

Learn how you could future-proof your supply chain and ensure the cell therapy industry is able to meet growing demand and listen to Ali share his insights today.

Ali Mohamed will also be speaking at the Onco Cell Therapy Summit (OCTS, 7-9 July, 2020), taking place virtually. Complete the form below to hear Ali Mohamed’s expert insight plus find more information about OCTS.



Visit kisacoresearch.com/events/octs-2020 for the full agenda and to register to attend. Alternatively, contact Kisaco Research for more details at: [email protected]